EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer

Ebaa Al-Obeidi, Jonathan W Riess, Umberto Malapelle, Christian Rolfo, David R Gandara

Hematology/Oncology Clinics of North America · 2023

DOI: 10.1016/j.hoc.2023.02.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Hematology/Oncology Clinics of North America, 2023. Verfasst von Ebaa Al-Obeidi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA. Electronic address: ealobeidi…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Circulating Tumor DNA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 68 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review article illuminates the role of liquid biopsy in the continuum of care for non-small cell lung cancer (NSCLC). We discuss its current application in advanced-stage NSCLC at the time of diagnosis and at progression. We highlight research showing that concurrent testing of blood and tissue yields faster, more informative, and cheaper answers than the standard stepwise approach. We also describe future applications for liquid biopsy including treatment response monitoring and testing for minimal residual disease. Lastly, we discuss the emerging role of liquid biopsy for screening and early detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsCirculating Tumor DNAHumansPrecision MedicineBiomarkers, TumorLiquid Biopsy

Stichwörter der Autor:innen

Circulating tumor DNA (ctDNA)Liquid biopsyMinimal residual disease (MRD)Next-generation sequencing (NGS)Non-small cell lung cancer (NSCLC)Tumor mutational burden (TMB)

Substanzen

Circulating Tumor DNABiomarkers, Tumor

Autor:innen und Institutionen

  • Division of Hematology-Oncology, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA. Electronic address: ealobeidi@ucdavis.edu.
  • Division of Hematology-Oncology, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA.
  • Department of Public Health, University of Naples Federico II, Via Sergio Pansini 5, 80131, Naples, Italy. Electronic address: https://twitter.com/UmbertoMalapel1.
  • Center for Thoracic Oncology at the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, One Gustave Levy Place, Box 1079, New York, NY 10029, USA. Electronic address: https://twitter.com/ChristianRolfo.
  • Division of Hematology-Oncology, University of California, Davis, 4501 X Street, Suite 3016, Sacramento, CA 95817, USA. Electronic address: https://twitter.com/drgandara.

Zitieren

APA

Al-Obeidi, E., Riess, J. W., Malapelle, U., Rolfo, C., & Gandara, D. R. (2023). Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer. Hematology/Oncology Clinics of North America. https://doi.org/10.1016/j.hoc.2023.02.005

Vancouver

Al-Obeidi E, Riess JW, Malapelle U, Rolfo C, Gandara DR. Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer. Hematology/Oncology Clinics of North America. 2023. doi:10.1016/j.hoc.2023.02.005

BibTeX
@article{AlObeidi2023,
  author = {Al-Obeidi, Ebaa and Riess, Jonathan W and Malapelle, Umberto and Rolfo, Christian and Gandara, David R},
  title = {Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer},
  journal = {Hematology/Oncology Clinics of North America},
  year = {2023},
  doi = {10.1016/j.hoc.2023.02.005}
}
Kostenlos starten →